Epiphora

18 registered clinical trials studyying Epiphora — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in NCT07372014	Instituto de Oftalmología Fundación Conde de Valenciana	Phase 4
Completed	Examination of Lacrimal Sac and Nasal Mucosa Preparations Taken in Dacryocystorhinostomy Surgery of Patients W NCT06810089	Uludag University	—
Terminated	SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction NCT03705000	Thomas Gardner	N/A
Completed	Topical Cyclosporine-A for Management of Epiphora NCT04637633	Farwaniya Hospital	Phase 2 / Phase 3
Recruiting	Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain? NCT05663684	Louisiana State University Health Sciences Center in New Orleans	Phase 4
Terminated	Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain? NCT04229771	Corewell Health East	Phase 4
Unknown	Placement of Three Interrupted Sutures After Triangular Three-snip Punctoplasty NCT04680078	Menoufia University	N/A
Unknown	Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR NCT04833452	Menoufia University	N/A
Unknown	Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome. NCT02849093	Bedford Hospital NHS Trust	—
Completed	Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients NCT02503956	Rabin Medical Center	N/A
Withdrawn	Bupivacaine Epiphora Trial NCT03266081	McMaster University	Phase 2
Completed	The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora NCT02240615	Sinopsys Surgical	EARLY_Phase 1
Completed	Management of Lower Punctal Stenosis. NCT03731143	Menoufia University	N/A
Completed	Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora NCT01282541	Merbs, Shannath, M.D., Ph.D.	Phase 2
Completed	The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora NCT01010659	Aurolab	Phase 4
Withdrawn	Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel NCT00824811	M.D. Anderson Cancer Center	Phase 2
Completed	Lacrimal Drainage Resistance Study NCT01766232	The Cleveland Clinic	—
Completed	Prevention of Docetaxel Induced Dacryostenosis NCT00266838	Universitaire Ziekenhuizen KU Leuven	Phase 1